A novel phosphoprotein

Details for Australian Patent Application No. 2003287764 (hide)

Owner The Walter and Eliza Hall Institute of Medical Research

Inventors Visvader, Jane; Olayioye, Monilola; Hoffmann, Peter; Pomorski, Thomas; Lindeman, Geoffrey

Agent The Walter and Eliza Hall Institute of Medical Research

Pub. Number AU-B-2003287764

PCT Number PCT/AU2003/0016

PCT Pub. Number WO2004/055047

Priority 2002953341 13.12.02 AU

Filing date 12 December 2003

Wipo publication date 9 July 2004

Acceptance publication date 21 January 2010

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61P 35/00 (2006.01) Antineoplastic agents

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 2002953341 13.12.02 AU

19 August 2004 Application Open to Public Inspection

  Published as AU-B-2003287764

21 January 2010 Application Accepted

  Published as AU-B-2003287764

20 May 2010 Standard Patent Sealed

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287765-MEETHOD OF DIAGNOSIS,TREATMENT AND USEFUL AGENTS FOR CONDITIONS CHARACTERISED BY MODULATION IN THE LEVEL OF ACTIVIN BetaC.

2003287763-BORE VERTICAL SLIT CORE CARRIER